NCT02827656View on ClinicalTrials.gov

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

NAUnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

December 31, 2017

Conditions
Infertility
Interventions
DRUG

Decapeptyl

luteal support as described and vaginal progesterone 200 mg 3 times a day

DRUG

hCG luteal support

luteal support as described and vaginal progesterone 200 mg 3 times a day

Sponsors
All Listed Sponsors
lead

Meir Medical Center

OTHER